FTV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Fortive Corp (FTV) is not a strong buy at this time for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock has shown a significant regular market decline (-4.62%) and lacks strong positive signals from technical indicators, options sentiment, or proprietary trading signals. Additionally, insider selling has surged, and the company's recent financial performance shows declining revenue and net income. While some analysts have raised price targets, the overall sentiment remains mixed, with notable downgrades and concerns about growth risks. Given the lack of immediate positive catalysts and the investor's preference for long-term stability, holding off on purchasing FTV is recommended.
The technical indicators are mixed. The MACD is positive but contracting, RSI is neutral at 39.064, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock closed below the pivot level (57.571) at 55.94, indicating potential weakness. Key support levels are at 53.755 and 51.398, while resistance levels are at 61.388 and 63.745.
The company reported better-than-expected Q4 operating results, including a healthy 3.8% operating beat and strong free cash flow conversion (109%).
Analysts have expressed concerns about growth risks, funding delays, and demand uncertainty in key segments. No recent news or congress trading data to provide support.
In Q4 2025, revenue dropped by -30.72% YoY to $1.122 billion, net income fell by -11.06% YoY to $185.7 million, and EPS decreased by -3.33% YoY to 0.58. However, gross margin improved by 4.71% YoY to 63.15%. Overall, the financial performance reflects declining growth trends despite some operational efficiency improvements.
Analyst sentiment is mixed. Recent upgrades include price target increases to $63-$70 from firms like Barclays, Citi, and Seaport Research, citing solid Q4 results and potential value from the Ralliant spin-off. However, JPMorgan and Mizuho have downgraded the stock, citing risks in organic growth, demand uncertainty, and a slow start to 2026 for key segments.
